Advertisement
Australia markets closed
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • AUD/USD

    0.6421
    -0.0004 (-0.07%)
     
  • OIL

    83.24
    +0.51 (+0.62%)
     
  • GOLD

    2,406.70
    +8.70 (+0.36%)
     
  • Bitcoin AUD

    100,340.72
    +1,194.61 (+1.20%)
     
  • CMC Crypto 200

    1,334.09
    +21.46 (+1.64%)
     
  • AUD/EUR

    0.6023
    -0.0008 (-0.13%)
     
  • AUD/NZD

    1.0893
    +0.0018 (+0.17%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,037.65
    -356.67 (-2.05%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • Dow Jones

    37,986.40
    +211.02 (+0.56%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

Sisram Medical Ltd (HKG:1696): A Fundamentally Attractive Investment

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card!

Sisram Medical Ltd (HKG:1696) is a stock with outstanding fundamental characteristics. When we build an investment case, we need to look at the stock with a holistic perspective. In the case of 1696, it is a company with great financial health as well as a an impressive track record of performance. Below is a brief commentary on these key aspects. For those interested in understanding where the figures come from and want to see the analysis, take a look at the report on Sisram Medical here.

Excellent balance sheet with proven track record

Over the past year, 1696 has grown its earnings by 98%, with its most recent figure exceeding its annual average over the past five years. Not only did 1696 outperformed its past performance, its growth also surpassed the Medical Equipment industry expansion, which generated a 23% earnings growth. This is an notable feat for the company. 1696 is financially robust, with ample cash on hand and short-term investments to meet upcoming liabilities. This implies that 1696 manages its cash and cost levels well, which is an important determinant of the company’s health. 1696 seems to have put its debt to good use, generating operating cash levels of 7.48x total debt in the most recent year. This is also a good indication as to whether debt is properly covered by the company’s cash flows.

SEHK:1696 Income Statement, May 23rd 2019
SEHK:1696 Income Statement, May 23rd 2019

Next Steps:

For Sisram Medical, I've put together three relevant factors you should further examine:

ADVERTISEMENT
  1. Future Outlook: What are well-informed industry analysts predicting for 1696’s future growth? Take a look at our free research report of analyst consensus for 1696’s outlook.

  2. Valuation: What is 1696 worth today? Is the stock undervalued, even when its growth outlook is factored into its intrinsic value? The intrinsic value infographic in our free research report helps visualize whether 1696 is currently mispriced by the market.

  3. Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of 1696? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.